GENEON

Synthetic Biology & DNA Synthesis
technologies

ABOUT US

A commitment to innovation

Re-writing the code of life

GENEON is a pioneering start-up venturing into the fast growing field of Synthetic Biology, a transformative technology that holds vast potential, with applications spanning biomanufacturing, agriculture, food production, environmental sustainability, and medicine.

About us

Start-up company, (est. 2023), with the vision to innovate solutions
for the global Synthetic Biology market

Our Orientation

At the heart of our endeavours is DNA synthesis, the art and science of crafting artificial DNA molecules.

Our Technology

Our advanced technology will be able to construct synthetic DNA of customisable sequence, extending up to Mbp/Gbp length. 

Our Target

We aim to become the world’s premier provider of large, custom-designed DNA molecules.

TEAM

Nicolas Kylilis, PhD
CEO & CTO

  • PhD in “Synthetic & Molecular Biology” from Imperial College London
  • Long experience in biotechnology R&D including Imperial College London, the UK National Center for Synthetic Biology, and the Dept. of Biological Sciences at the University of Cyprus. 

Gravity Ventures
Incubator

  • Cutting-edge, venture building incubator that fosters and propels innovation.
  • Empowers founders to make real impact and shape the entrepreneurial community of tomorrow.
  • Gravity’s approach focuses on building startups from early-stage to mature ventures, by assisting them in all the necessary steps and being with them throughout their journey.

CyRIC
Business Innovation Center

  • Develops disruptive products for the world markets and providing unique, high quality services to the industry.
  • CYRIC offers Research and Innovation Services for its customers including a number of specialised consultancy and entrepreneurship services to startups and SMEs

TECHNOLOGY

proprietary

High-Performance
DNA Assembly technology

On-demand outsourced synthesis of XL-DNA fragments

BioFoundries

  • Infrastructure savings & labour cost optimisation
  • Adaptable operations scaling
  • Innovative solutions to clients
  • Fewer QC interventions & Accelerated Innovation

Companies

  • Focus on product development by outsourcing DNA Assembly
  • Fast turnaround for expedited project timelines
  • Accessibility to state-of-art DNA assembly technologies
  • Expansion to other new markets

Academic Labs

  • Focus on research topic by outsourcing DNA Assembly
  • Fast turnaround for expedited project timelines
  • Accessibility to state-of-art DNA assembly technologies
  • Design of more complex genetic networks for novel research

MARKET

MARKET SIZE

Global
Synthetic Biology market (2022)
$13.09 billions

CAGR

18.97%
(2023-2030)

PRODUCT OUTLOOK

  • Synthetic DNA 35%
  • Enzymes 25%
  • Cloning Kits 20%
  • Xeno-Nucleic Acids 12%
  • Chassis Organism 7.5%


CONTACT US

First name

Last name

Subject

Email

Message

Success

Your form submitted successfully!

Error

Sorry! your form was not submitted properly, Please check the errors above.

NEWSLETTER

First name

Last name

Email

Organisation Affiliation / Personal

Success

Your form submitted successfully!

Error

Sorry! your form was not submitted properly, Please check the errors above.